Clinical significance of neurobiochemical profiles in the lumbar cerebrospinal fluid of Alzheimer’s disease patients
- 1 June 2001
- journal article
- research article
- Published by Springer Science and Business Media LLC in Journal of Neural Transmission
- Vol. 108 (2), 231-246
- https://doi.org/10.1007/s007020170091
Abstract
No abstract availableKeywords
This publication has 85 references indexed in Scilit:
- Three-year follow-up of cerebrospinal fluid tau, β-amyloid 42 and 40 concentrations in Alzheimer's diseaseNeuroscience Letters, 2000
- Intra vitam lumbar cerebrospinal fluid and serum and postmortem ventricular immunoreactive apolipoprotein E in patients with Alzheimer's disease.Journal of Neurology, Neurosurgery & Psychiatry, 1996
- Cerebrospinal fluid apolipoprotein E is reduced in Alzheimerʼs diseaseNeuroReport, 1994
- Central Nervous System IgG Synthesis Rates in Alzheimer DiseaseAlzheimer Disease & Associated Disorders, 1994
- Tau protein and the neurofibrillary pathology of Alzheimer's diseaseTrends in Neurosciences, 1993
- Apolipoprotein E: Binding to Soluble Alzheimer′s β-AmyloidBiochemical and Biophysical Research Communications, 1993
- Interleukin‐6 and α‐2‐macroglobulin indicate an acute‐phase state in Alzheimer's disease corticesFEBS Letters, 1991
- Neurotrophic and Neurotoxic Effects of Amyloid β Protein: Reversal by Tachykinin NeuropeptidesScience, 1990
- Intra-Blood-Brain-Barrier Synthesis of Immunoglobulins in Patients with Dementia of the Alzheimer TypeAlzheimer Disease & Associated Disorders, 1990
- Clinical diagnosis of Alzheimer's diseaseNeurology, 1984